Research/art/teacher profile of a person

Name and surname:	PharmDr. Martin Kertys, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname

Kertys

I.2 - Name

Martin

I.3 - Degrees

PharmDr., PhD.

I.4 - Year of birth

1989

I.5 - Name of the workplace

Department of pharmacology

I.6 - Address of the workplace

Mala Hora 4/C, 036 01 Martin, Slovakia

I.7 - Position

assistant proffesor

I.8 - E-mail address

martin.kertys@uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/29949

I.10 - Name of the study field in which a person works at the university

General medicine

I.11 - ORCID iD

0000-0002-1095-6810

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

University of Veterinary Medicine and Pharmacy in Košice

II.b - Year

2014

II.c - Study field and programme

7.3.1. Pharmacy, pharmacy

II.3 - Third degree of higher education

II.a - Name of the university or institution

Jessenius Faculty of Medicine in Martin Comenius University Bratislava

II.b - Year

2018

II.c - Study field and programme

pharmacology

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
researcher	Jessenius Faculty of Medicine in Martin Comenius University Bratislava	28.8.2018-31.8.2019
assistant proffesor	Jessenius Faculty of Medicine in Martin Comenius University Bratislava	1.10.2019-ongoing

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Pharmacology	General medicine	I.+II.	General medicine
Pharmacology	Dentistry	I.+II.	Dentistry
Pharmacology	Nursing, Midwifery, Public Health	I.	Nursing, Midwifery, Public Health

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.2.a - Name of the study programme	V.2.b - Degree	V.2.c - Field of study
Pharmacology	III.	pharmacy

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.a - Bachelor's (first degree)

0

V.4.b - Diploma (second degree)

7

V.4.c - Dissertation (third degree)

0

V.4.2 - Number of defended theses

V.4.a - Bachelor's (first degree)

0

V.4.b - Diploma (second degree)

13

V.4.c - Dissertation (third degree)

1

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

83

VI.1.b - Over the last six years

42

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

38

VI.1.b - Over the last six years

23

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

117

VI.1.b - Over the last six years

57

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

105

VI.1.b - Over the last six years

54

VI.1.5 - Number of invited lectures at the international, national level

VI.1.a - Overall

0

VI.1.b - Over the last six years

0

VI.2 - The most significant research/artistic/other outputs

1

Effects of tadalafil (PDE5inhibitor) and roflumilast (PDE4 inhibitor) on airway reactivity and markers of inflammation in ovalbumin-induced airway hyperresponsiveness in guinea pigs

2

Inhibitors of phosphodiesterases in the treatment of cough

3

Plasma-based targeted metabolomic analysis reveals alterations of phosphatidylcholines and oxidative stress markers in guinea pig model of allergic asthma

4

Simultaneous determination of fluoxetine, venlafaxine, vortioxetine and their active metabolites in human plasma by LC-MS/MS using one-step sample preparation procedure

5

Simultaneous determination of caffeine and its metabolites in rat plasma by UHPLC-MS/MS

VI.3 - The most significant research/artistic/other outputs over the last six years

1

Metabolomic characterisation of progression and spontaneous regression of melanoma in the melanoma-bearing Libechov minipig model

2

A high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous determination of direct oral anticoagulants in human plasma

3

Plasma-based targeted metabolomic analysis reveals alterations of phosphatidylcholines and oxidative stress markers in guinea pig model of allergic asthma

4

Simultaneous determination of fluoxetine, venlafaxine, vortioxetine and their active metabolites in human plasma by LC-MS/MS using one-step sample preparation procedure

5

Simultaneous determination of caffeine and its metabolites in rat plasma by UHPLC-MS/MS

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

1

Simultaneous determination of fluoxetine, venlafaxine, vortioxetine and their active metabolites in human plasma by LC–MS/MS using one-step sample preparation procedure - citované v/cited in: Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood

2

Plasma based targeted metabolomic analysis reveals alterations of phosphatidylcholines and oxidative stress markers in guinea pig model of allergic asthma - citované v/cited in: Understanding uncontrolled severe allergic asthma by integration of omic and clinical data

3

Development of Sensitive and High-Throughput Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Haloperidol in Human Plasma with Phospholipid Removal Pretreatment - citované v/cited in: PVP-coated silver nanocubes as RRS probe for sensitive determination of Haloperidol in real samples

4

Plasma based targeted metabolomic analysis reveals alterations of phosphatidylcholines and oxidative stress markers in guinea pig model of allergic asthma - citované v/cited in: Detection of serum phospholipids by microchannel-integrated black phosphorus-assisted laser desorption/ionization mass spectrometry

5

Simultaneous determination of fluoxetine, venlafaxine, vortioxetine and their active metabolites in human plasma by LC–MS/MS using one-step sample preparation procedure - citované v/cited in: A new electrochemical sensor based on Europium-doped NiO nanocomposite for detection of venlafaxine

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

1

VEGA project, Monitoring účinnosti antiagregačnej a antikoagulačnej liečby, zodpovedný riešiteľ

2

VEGA projekt, Zvýšenie efektivity antitrombotickej terapie pomocou mini-invazívnej odberovej techniky, zodpovedný riešiteľ

3

APVV project, Rezistencia na antituberkulotiká – nové možnosti jej detekcie

a terapeutického manažmentu, člen riešiteľského kolektívu

4

VEGA project, Analýza hladín liečiv a laboratórnych markerov pri vybraných

psychiatrických ochoreniach, člen riešiteľského kolektívu

5

VEGA project, Nové možnosti detekcie rezistencie tuberkulóznych a netuberkulóznych mykobaktérií a ich terapeutické implikácie

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update

2025-01-30